Literature DB >> 22654248

Radioembolization complicated by dissection of the common femoral artery.

Sarah G Deitch1, Ramona Gupta.   

Abstract

The common femoral artery is the most frequently used access site for angiographic procedures in interventional radiology. Potential complications of common femoral arteriotomy include hematoma formation, pseudoaneurysm, uncontrolled groin or retroperitoneal bleeding, acute arterial occlusion, dissection, and arteriovenous fistula formation. In a case such as the one described here, with a common femoral artery dissection with intraluminal thrombus and vessel occlusion, the complication may have occurred at the time of access or at the time of closure, with both procedure-associated and patient-specific risk factors affecting the overall risk of complications. Though some studies have shown an increased risk of complications with the use of arterial closure devices, others have found no increase. In any patient with symptoms following a femoral arteriotomy, rapid diagnosis and treatment is necessary to avoid further complications. Both patient-specific and procedure-associated risk factors should be considered prior to arteriotomy and usage of an arterial closure device.

Entities:  

Keywords:  Dissection; angiogram; closure device; common femoral artery

Year:  2011        PMID: 22654248      PMCID: PMC3193314          DOI: 10.1055/s-0031-1280650

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  21 in total

1.  Optimizing safe femoral access during cardiac catheterization.

Authors:  K S Spector; W E Lawson
Journal:  Catheter Cardiovasc Interv       Date:  2001-06       Impact factor: 2.692

2.  PERCUTANEOUS TRANSFEMORAL ARTERIOGRAPHY: AN ANALYSIS OF THE COMPLICATIONS IN 1,000 CONSECUTIVE CASES.

Authors:  M HALPERN
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1964-10

Review 3.  Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis.

Authors:  Eugenia Nikolsky; Roxana Mehran; Amir Halkin; Eve D Aymong; Gary S Mintz; Zoran Lasic; Manuela Negoita; Martin Fahy; Shoshana Krieger; Issam Moussa; Jeffrey W Moses; Gregg W Stone; Martin B Leon; Stuart J Pocock; George Dangas
Journal:  J Am Coll Cardiol       Date:  2004-09-15       Impact factor: 24.094

4.  Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty.

Authors:  Fausto Biancari; Vito D'Andrea; Carlo Di Marco; Grazia Savino; Valentina Tiozzo; Antonio Catania
Journal:  Am Heart J       Date:  2010-04       Impact factor: 4.749

Review 5.  Techniques for managing complications of arterial closure devices.

Authors:  Venkat R Kalapatapu; Ahsan T Ali; Farzad Masroor; Mohammed M Moursi; John F Eidt
Journal:  Vasc Endovascular Surg       Date:  2006 Oct-Nov       Impact factor: 1.089

6.  Incidence and results of arterial complications among 16,350 patients undergoing cardiac catheterization.

Authors:  S C Babu; G O Piccorelli; P M Shah; J H Stein; R H Clauss
Journal:  J Vasc Surg       Date:  1989-08       Impact factor: 4.268

7.  Complications of transluminal angioplasty.

Authors:  G A Gardiner; M F Meyerovitz; K R Stokes; M E Clouse; D P Harrington; M A Bettmann
Journal:  Radiology       Date:  1986-04       Impact factor: 11.105

8.  Vascular complications of cardiac catheterization.

Authors:  R L McCann; L B Schwartz; K S Pieper
Journal:  J Vasc Surg       Date:  1991-09       Impact factor: 4.268

9.  Complications associated with the arterial puncture closure device--Angio-Seal.

Authors:  Alexander Kadner; Jürg Schmidli; Igor Schwegler; Florian Dick; Florian Schönhoff; Thierry Carrel; Hannu Savolainen
Journal:  Vasc Endovascular Surg       Date:  2008-01-29       Impact factor: 1.089

10.  Local vascular complications after use of the hemostatic puncture closure device Angio-Seal.

Authors:  C Kirchhof; S Schickel; C Schmidt-Lucke; J A Schmidt-Lucke
Journal:  Vasa       Date:  2002-05       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.